Effectiveness and Safety of Fluticasone Propionate in Adolescents and Adults Who Have Asthma

Study Title

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Teva Identifier

FpS-AS-202 | 2010-023601-35

ClinicalTrials.gov Identifier

NCT01576718

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Fp MDPI | Other: Placebo MDPI | Drug: Flovent Diskus | Drug: albuterol/salbutamol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

04/01/2012 - 10/01/2013

Phase

Phase 2

Study Type

Interventional